evolocumab
cergutuzumab
bispecific
-axo-
Forssman antibody
heterophil antibody
atezolizumab
idiospecific
antiantibody
reagin
heterophile antibody
antigenomic
conatumumab
panitumumab
drozitumab
intrabody
biciromab
oleclumab
polyantibody
bococizumab
antigenic
alloantibody
-ab
sulesomab
zolimomab
immunospecific
-a-
polyvalent
complement
agonistic monoclonal antibody
immunoprobe
Ab
bezlotoxumab
antihuman
-i-
presentation
olendalizumab
polytypic
monoclonal
antisynthetase
siltuximab
multiantigen
immunoprecipitant
brentuximab
properdin
onartuzumab
antipolyvalent
immunonaive
polyantigenic
robatumumab